Nvidia is joining with Abridge, maker of an AI note-taking app for doctors, to train an artificial intelligence model tailored for healthcare as it continues its push into the sector. The AI model is ...

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

Cybercriminals have been using AI to identify and exploit a zero-day vulnerability successfully for the first time, Google Threat Intelligence Group (GTIG) has warned. Published on May 11, the GTIG AI ...

Standard Intelligence Inc., a six-person artificial intelligence startup, today announced that it has raised $75 million in funding. Sequoia and Spark Capital led the round. They were joined by ...

Every time I take a break from running and then resume the activity, I remember why people say that running is hard. It is because running is hard. It is difficult to persist through strain long-term, ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

McKinney-based Craig International is planning to develop a 189-acre mixed-use project in Denison, positioned as a gateway to the Lake Texoma region. The firm emerged as the winner following a ...

Research from Poland adds to evidence from Latin American countries that compounds in used cigarette butts ward off parasites in bird nests. By Lesley Evans Ogden Darwin’s finches in the Galápagos, ...

An interdisciplinary research team from two working groups at the Center for Synthetic Biology at TU Darmstadt has developed the first RNA-based genetic switch that precisely replicates the logical ...

What we know so far: Nvidia is reportedly developing a second variant of its entry-level GeForce RTX 5050 graphics card with 9GB of VRAM, compared to the 8GB configuration on the original model. The ...

Target-trial emulation in VA EHRs constructed eight parallel new-user trials comparing GLP-1 RA initiators with SGLT-2 inhibitor initiators under two protocols: incident SUDs and SUD-related adverse ...